|
|
| Model Number |
8888200001 |
| Medical Device Problem Code |
Detachment of Device or Device Component (2907)
|
| Health Effect - Clinical Codes |
Cardiac Arrest (1762); Hemorrhage/Blood Loss/Bleeding (1888); Ventricular Fibrillation (2130); Asystole (4442)
|
| Date of Event |
03/14/2025
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
According to the reporter, during long-term dialysis, the venous port was disconnected, which led to significant blood loss.The patient became pulseless, and cpr (cardiopulmonary resuscitation) started.They noted the rhythm was vfib (ventricular fibrillation) and then asystole.The patient underwent a massive blood transfusion protocol.Rosc (return of spontaneous circulation) was unable to be achieved.The patient passed away.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: e1(facility name, fax number).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: b2 (outcome attributed to adverse event, date of death), b5, d6a, g3, h11.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
According to the reporter, on the day of the event, the patient was in the er (emergency room) for emesis, elevated wbc (white blood cells), and hgb (hemoglobin) 6.4.Based on lab work, dialysis was needed, and the patient was taken to the dialysis unit.The blood flow for dialysis was 400, which was consistent with normal treatment prescription.According to their records, the bloodline connection was secure and had a connector on it that secured the bloodlines to the catheter (was referred to as a secure lock).Shortly after the start of long-term dialysis, the dialysis machine alarmed.The nurse responded to the machine alarm, and it was found that the venous port/hub had disconnected, which led to significant blood loss.The rapid response team was engaged.The machine was maintained by the 3rd parties biomed.For the hospital, it stated the machine was not a concern; it did what it was supposed to and alarmed according to the 3rd party.The machines were maintained by a 3rd party, as they were the 3rd party¿s equipment.The hospital did not have access to verify the machine alarmed.The patient was non-compliant, and there was no information on how the catheter had cared for/maintained outside of dialysis sessions.The patient was known to move a bit during the treatment, so there might have been some tension.No cracks or concerns with the catheter upon inspection.They investigated if the catheter should have been removed and replaced earlier but could not find anything that indicated a usage/timing limit.The patient became pulseless, and cpr (cardi opulmonary resuscitation) started.They noted the rhythm was vfib (ventricular fibrillation) and then asystole.The patient underwent a massive blood transfusion protocol.Rosc (return of spontaneous circulation) was unable to be achieved.The patient passed away on the same day as the event.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
According to the reporter, on the day of the event, the patient was in the er (emergency room) for emesis, elevated wbc (white blood cells), and hgb (hemoglobin) 6.4.Based on lab work, dialysis was needed, and the patient was taken to the dialysis unit.The blood flow for dialysis was 400, which was consistent with normal treatment prescription.According to their records, the bloodline connection was secure and had a connector on it that secured the bloodlines to the catheter (was referred to as a secure lock).Shortly after the start of long-term dialysis, the dialysis machine alarmed.The nurse responded to the machine alarm, and it was found that the venous port/hub had disconnected, which led to significant blood loss.The rapid response team was engaged.The machine was maintained by the 3rd parties biomed.For the hospital, it stated the machine was not a concern; it did what it was supposed to and alarmed according to the 3rd party.The machines were maintained by a 3rd party, as they were the 3rd party¿s equipment.The hospital did not have access to verify the machine alarmed.It was confirmed that the catheter had previously undergone a repair on (b)(6) 2024.The locum provider¿s note did not provide specific information about the repair procedure, but there was no need for both l imbs to be repaired since it was the clamp part from the catheter that was repaired.The disconnection of the luer adapter occurred on the venous limb of the catheter, aligning with the side where the clamp was repaired in november.The hospital noted that the only available repair kit at the time of the november repair was the one now identified as the kit from which the luer adapter that disconnected is believed to have originated.There was no documentation to indicate the catheter had been repaired or altered again after that date.The patient was non-compliant, and there was no information on how the catheter cared for/maintained outside of dialysis sessions.The patient had a pre-existing condition of chronic pain, and staff reported that the patient constantly moved around in the chair/bed during dialysis treatment, which might have contributed to some tension on the catheter.No cracks or obvious damage to the catheter were observed upon inspection by staff.They investigated if the catheter should have been removed and replaced earlier but could not find anything that indicated a usage/timing limit.The patient became pulseless, and cpr (cardiopulmonary resuscitation) started.They noted the rhythm was vfib (ventricular fibrillation) and then asystole.The patient underwent a massive blood transfusion protocol.Rosc (return of spontaneous circulation) was unable to be achieved.The patient passed away on the same day as the event.
|
| |
|
Additional Manufacturer Narrative
|
|
H3.Evaluation summary: medtronic conducted an investigation based upon all information received.The device was not returned, but a photo was available for evaluation.Visual inspection noted a detached venous port and clip, with visible signs of use such as blood.There appeared to be no other abnormalities with the device.It was reported that luer adapter detached from the extension tube.The reported issue was confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|
|
|